AGILENT TECHNOLOGIES INC

CIK:0001090872|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
Net revenue:
Net revenue	$ 1,878	$ 1,738	$ 5,511	$ 5,087
Costs and expenses:
Cost of revenue	836	850	2,533	2,434
Research and development	123	111	366	336
Selling, general and administrative	475	417	1,416	1,281
Total costs and expenses	1,434	1,378	4,315	4,051
Income from operations	444	360	1,196	1,036
Interest income	15	16	43	45
Interest expense	(29)	(28)	(79)	(85)
Other income (expense), net	14	18	56	(3)
Income before taxes	444	366	1,216	993
Provision for income taxes	82	30	210	124
Net income	$ 362	$ 336	$ 1,006	$ 869
Net income per share
Basic	$ 1.28	$ 1.18	$ 3.55	$ 3.05
Diluted	$ 1.28	$ 1.18	$ 3.55	$ 3.05
Weighted average shares used in computing net income per share:
Basic	282	284	283	285
Diluted	283	285	283	285
Product
Net revenue:
Net revenue	$ 1,333	$ 1,230	$ 3,911	$ 3,616
Costs and expenses:
Cost of revenue	559	577	1,697	1,650
Services and Other
Net revenue:
Net revenue	545	508	1,600	1,471
Costs and expenses:
Cost of revenue	$ 277	$ 273	$ 836	$ 784

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Jul. 31, 2026	Jul. 31, 2025
Cash flows from operating activities
Net income	$ 1,006.0	$ 869.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	200.0	217.0
Share-based compensation	105.0	102.0
Deferred taxes expense (benefit)	77.0	(35.0)
Excess and obsolete inventory related charges	35.0	30.0
Net gain (loss) on equity securities	(2.0)	(28.0)
Asset, Impairment Loss	0.0	15.0
Other non-cash income (expense), net	(12.0)	(4.0)
Changes in assets and liabilities:
Accounts receivable,net	16.0	(44.0)
Inventory	(110.0)	(72.0)
Accounts payable	41.0	(13.0)
Employee compensation and benefits	(25.0)	(26.0)
Other assets and liabilities	(295.0)	(61.0)
Net cash provided by operating activities	1,064.0	1,014.0
Cash flows from Investing activities:
Payments to acquire property, plant and equipment	(249.0)	(314.0)
Proceeds from sale of equity securities	0.0	5.0
Proceeds from convertible note	0.0	2.0
Payments in exchange for convertible note	(3.0)	(1.0)
Payments to acquire businesses and intangible assets, net of cash acquired	(950.0)	4.0
Net cash used in investing activities	(1,202.0)	(304.0)
Cash flows from financing activities:
Proceeds from issuance of common stock under employee stock plans	63.0	60.0
Payments of taxes related to net share settlement of equity awards	(31.0)	(28.0)
Payments for repurchase of common stock	(295.0)	(340.0)
Payment of excise taxes related to repurchases of common stock	(3.0)	(10.0)
Payments of dividends	(216.0)	(212.0)
Proceeds from Issuance of Long-Term Debt	600.0	4.0
Repayments of Long-Term Debt	(4.0)	(2.0)
Payments of Debt Issuance Costs	(5.0)	0.0
Net proceeds from (repayments of) short-term debt	0.0	13.0
Repayment of finance lease	(4.0)	0.0
Net cash provided by (used in) financing activities	105.0	(515.0)
Effect of Exchange Rate Movements	2.0	10.0
Net increase (decrease) in cash, cash equivalents and restricted cash	(31.0)	205.0
Cash, cash equivalents and restricted cash at beginning of period	1,791.0	1,332.0
Cash, cash equivalents and restricted cash at end of period	1,760.0	1,537.0
Supplemental cash flow information:
Income tax paid, net of refunds received	376.0	304.0
Interest payments, net of capitalized interest	47.0	55.0
Net change in property, plant and equipment included in Accounts Payable and Accrued Liabilities increase (decrease)	(9.0)	0.0
Excise taxes on share repurchases, accrued but not paid	$ 2.0	$ 2.0

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Jul. 31, 2026	Oct. 31, 2025
Current assets:
Cash and cash equivalents	$ 1,758	$ 1,789
Accounts receivable, net	1,478	1,487
Inventory	1,117	1,025
Other current assets	340	293
Total current assets	4,693	4,594
Property, plant and equipment, net	2,134	2,023
Goodwill	5,030	4,473
Other intangible assets, net	906	445
Long-term investments	130	133
Other assets	1,074	1,059
Total assets	13,967	12,727
Current liabilities:
Accounts payable	608	570
Employee compensation and benefits	423	443
Deferred revenue	640	624
Short-term debt	304	304
Other accrued liabilities	314	406
Total current liabilities	2,289	2,347
Long-term debt	3,645	3,050
Retirement and post-retirement benefits	128	126
Other long-term liabilities	542	463
Total liabilities	6,604	5,986
Commitments and Contingencies (Note 13)
Stockholders' equity:
Preferred stock; $0.01 par value; 125,000,000 shares authorized; none issued and outstanding at July 31, 2026 and October 31, 2025	0	0
Common stock; $0.01 par value; 2,000,000,000 shares authorized; 281,965,813 shares at July 31, 2026 and 283,054,377 shares at October 31, 2025, issued and outstanding	3	3
Additional paid-in-capital	5,681	5,575
Retained earnings	1,912	1,389
Accumulated other comprehensive loss	(233)	(226)
Total stockholders' equity	7,363	6,741
Total liabilities and stockholders' equity	$ 13,967	$ 12,727